Anggot, Cristyl .
HRN: 22-20-76 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/07/2022
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
12/07/2022
12/13/2022
IV
500 Mg
Q8
4th Degree Perineal Laceration
Waiting Final Action
Indication: Prophylaxis Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes